-
In this issue: Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
-
These authors assessed the benefits of antiviral therapy of the index flu patient on reduced viral shedding and prevention of secondary household cases who did not receive chemoprophylaxis.
-
Piperacillin/Tazobactam (P/T) offers one of the broadest antimicrobial spectrums, and is equipped with an effective mechanism to maintain its potency in the presence of beta-lactamases.
-
As recently discussed in Infectious Disease Alert (January 2010), chronic Hepatitis E virus (HEV) infection has been described in solid-organ transplant recipients, and uncommonly in persons with HIV.
-
The Veterans Health Administration maintains a national automated information system (DSS) that contains hospital discharge and outpatient data for the entire system.
-
Clinical laboratories in Massachusetts are required to submit to the state all isolates of Streptococcus pneumoniae cultured from blood, cerebrospinal fluid, or other normally sterile body fluids from children < 18 years of age.
-
In this study, 496 adults and adolescents in Malawi, with history of recent documented invasive pneumococcal disease, were administered PCV7 or placebo in a randomized, double-blind, controlled trial, and were followed for 798 person-years. Eighty-eight percent of patients were HIV-infected.
-
The superiority of a particular surgical-site preparation regimen in preventing surgical-site infection (SSI) has not been determined.
-
A multicenter, cluster (household)-randomized, double-blind, double-dummy, controlled trial was conducted in 812 patients (¡Ý 15 kg, and ¡Ý 2 years of age) from 376 households at seven study centers in the United Kingdom, Ireland, France, and Israel.
-